Elevated levels of methylated CpG sites in the angiopoietin-like 4 (ANGPTL4) promoter, which are strongly linked to advanced tumor stage, lead to ANGPTL4 deregulation in HCC [178]. This evidence concerns the gene ANGPTL4 and neoplasm.